4th qtr EBITDA run rate was $95-100m. Don't have to factor in...

4th qtr EBITDA run rate was $95-100m. Don't have to factor in any growth rate to get to fy17 ebitda of c$360-400m.
The hy1 pro forma npat was $82m. Fy no growth npat $165m
Additionally the company has raised c$700m. If the proceeds of the raising were not used to for nextgen which arguably is more value accretive but used to pay down debt, the interest savings would be c$35m or c$25m npat
Conservative npat $190m. P/e under 20 times
No synergies or growth or nextgen included
Dyor